Stanza Digital Behavioral Therapy Shown to Address Fibromyalgia Patient Unmet Needs

This month, Swing Therapeutics presented data from a real-world trial of Stanza, an FDA-cleared digital behavioral therapy for treatment of fibromyalgia symptoms, at the 2023 annual meeting of Association for Behavioral and Cognitive Therapies. The analysis of the ongoing trial data (108 patients) supports Stanza’s clinically meaningful benefit in addressing unmet needs for fibromyalgia patients, … Read more » The post Stanza Digital Behavioral Therapy Shown to Address Fibromyalgia Patient Unmet Needs appeared first on Swing Therapeutics .